Search results for "Elmi"

showing 10 items of 767 documents

Changes in Daily Steps and Body Mass Index and Waist to Height Ratio during Four Year Follow-Up in Adults: Cardiovascular Risk in Young Finns Study

2017

Aims: Over the study years, there was a significant increase in body mass index (BMI) and waist-to-height ratio (WtHR) in middle aged Finnish adults. Methods: Data were obtained from 1033 Finnish adults from the Cardiovascular Risk in Young Finns Study in 2007 and 2011. Cohort study participants wore an Omron Walking Style One (HJ-152R-E) pedometer for five days and were grouped into those who increased, maintained and decreased their steps between 2007 and 2011. Paired samples t-test was used to compare body mass index (BMI) and waist-to-height ratio (WtHR) change values between the change groups in study years. Results: Among study population BMI and WtHR increase between study years was …

AdultMalemedicine.medical_specialtyBiolääketieteet - BiomedicineHealth Toxicology and Mutagenesisphysical activitylcsh:Medicinebody mass indexWalking030204 cardiovascular system & hematologywaist-to-height ratioArticle03 medical and health sciences0302 clinical medicinePaired samplesadultsfollow-upHumansMedicine030212 general & internal medicinepainoindeksita315FinlandaskelmittaritaikuisetWaist-to-height ratioWaist-Height Ratiopedometerphysical activity; pedometer; adults; follow-up; body mass index; waist-to-height ratiobusiness.industrylcsh:RSisätaudit - Internal medicinePublic Health Environmental and Occupational HealthFollow up studiesNaisten- ja lastentaudit - Gynaecology and paediatricsMiddle Agedta3121Middle agePedometerPhysical therapyPopulation studyFemalebusinessBody mass indexfyysinen aktiivisuusFollow-Up StudiesCohort studyInternational Journal of Environmental Research and Public Health
researchProduct

The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: The SURGE 2 practice-based study

2013

SURGE 2, a large-scale, practice-based study in 10 countries, evaluated the effects of telmisartan alone or with hydrochlorothiazide (HCTZ) on morning (06:00 – 11:59) home blood pressure (HBP) control. Hypertensive patients (clinic blood pressure [BP] 140/90 mmHg) received telmisartan 40 or 80 mg either alone or in combination with HCTZ 12.5 mg for 8 weeks. Treatment could be adjusted if clinic BP remained 140/90 mmHg. Clinic BP was measured in the morning prior to medication, and seated HBP monitoring was performed, three times per day, 2 days per week. A total of 25,882 patients were included (71% were previously using antihypertensives). There was a statistically signifi cant (all p 0.00…

AdultMalemedicine.medical_specialtyEveningAdolescentDiastoleBlood PressureBenzoatesYoung AdultHydrochlorothiazideInternal medicineInternal MedicinemedicineHumansProspective StudiesTelmisartanProspective cohort studyAdverse effectAntihypertensive AgentsMorningAgedAged 80 and overbusiness.industryHome blood pressure monitoring hydrochlorothiazide morning blood pressure control telmisartanGeneral MedicineMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring AmbulatoryMiddle AgedDrug CombinationsEndocrinologyBlood pressureHydrochlorothiazideAnesthesiaHypertensionBenzimidazolesFemaleTelmisartanCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor Blockersmedicine.drug
researchProduct

Ultrasonographical aspects of urinary schistosomiasis: Assessment of morphological lesions in the upper and lower urinary tract

1986

Ultrasonographic evaluation of 213 patients with urinary schistosomiasis in different age groups was performed in an endemic area of the Democratic Republic of Congo. The results were compared with 94 age matched controls without urinary schistosomiasis. In patients the bladder showed thickening of the wall, polypoid lesions of the mucosa and bladder wall, calcifications and urinary retention. Urinary tract obstruction, predominantly unilateral, was demonstrated. The lesions increased in severity with the intensity of infection, parallel to an increase in ova excretion. Children aged between 8 and 19 years were most severely affected. Pathological lesions of the upper urinary tract were rar…

AdultMalemedicine.medical_specialtyPathologyAdolescentUrinary systemUrinary BladderHelminthiasisSchistosomiasisKidneyGastroenterologySchistosomiasis haematobiaInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingChildPathologicalAgedUltrasonographyUpper urinary tractUrinary bladderUrinary retentionbusiness.industryInfantMiddle Agedmedicine.diseasemedicine.anatomical_structureChild PreschoolPediatrics Perinatology and Child HealthFemaleUretermedicine.symptomUrinary tract obstructionbusinessPediatric Radiology
researchProduct

Phenotypic analysis of peripheral lymphocyte subpopulations in hydatid patients.

1999

Peripheral T-lymphocytes were analyzed in three groups of people: (1) individuals with current liver hydatid disease (hydatid patients, n = 20), (2) persons who had undergone surgical cyst removal at least 2 years previously (recovered patients, n = 9), and (3) a control group of healthy volunteers (uninfected controls, n = 13). Group 1 was subdivided according to cyst status, relapse of disease, and the presence or absence of symptoms. Percentages of lymphocytes expressing CD3, CD4, CD8, CD56, CD25, CD45RA, CD45RO, and HLA-DR were determined. Symptomatic patients had proportionally fewer CD3+ CD8 + lymphocytes than the control group (P=0.038). Hydatid patients with active cysts had proport…

AdultMalemedicine.medical_specialtyPathologyEchinococcosis HepaticHelminthiasischemical and pharmacologic phenomenaBiologyGastroenterologyNatural killer cellImmunophenotypingImmune systemAntigens CDT-Lymphocyte SubsetsInternal medicineparasitic diseasesmedicineHumansCystIL-2 receptorEchinococcus granulosusAgedGeneral VeterinaryGeneral MedicineT lymphocyteMiddle Agedmedicine.diseasebiology.organism_classificationInfectious Diseasesmedicine.anatomical_structureInsect ScienceLeukocytes MononuclearParasitologyFemaleCD8Parasitology research
researchProduct

Angiotensin II antagonists - an assessment of their acute toxicity.

2013

In Germany, increasing prescription rates of angiotensin II antagonists resulted in rising enquiries to Poisons Information Centres (PICs) during the last decade. Therefore, we aimed to assess their acute toxicity for deriving triage recommendations.An observational case series with data collected retrospectively from eight PICs in Austria, Germany and Switzerland. Inclusion criteria were monoexposure, defined dose, and documented follow-up.In total, 206 cases of exposures to angiotensin II antagonists were included (candesartan, 94; eprosartan, 3; irbesartan, 20; losartan, 26; olmesartan, 16; telmisartan, 18; and valsartan, 29). The median dose expressed as a multiple of their maximum dail…

AdultMalemedicine.medical_specialtyPoison Control CentersTime FactorsPharmacologyToxicologyIrbesartanInternal medicineGermanymedicineHumansAntihypertensive AgentsRetrospective Studiesbusiness.industryPoisoningEprosartanGeneral MedicineMiddle AgedAngiotensin IILosartanValsartanChild PreschoolMedian bodyFemaleTelmisartanDrug OverdoseHypotensionbusinessOlmesartanAngiotensin II Type 1 Receptor Blockersmedicine.drugClinical toxicology (Philadelphia, Pa.)
researchProduct

High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia.

1999

Over a 6-year period, an epidemiological study of human infection by Fasciola hepatica in the Northern Bolivian Altiplano was carried out. Prevalences and intensities were analysed from coprological results obtained in 31 surveys performed in 24 localities and proved to be the highest known so far. The global prevalence was 15.4%, with local prevalences ranging from 0% to 68.2%. Significant differences between prevalence rates were detected and the highest prevalences were in subjects aged20 years. However, prevalences showed no gender difference. The global intensity (eggs per gram of faeces, epg) ranged from 24 to 5064 epg and showed arithmetic and geometric means respectively of 446 and …

AdultMalemedicine.medical_specialtyVeterinary medicineBoliviaFascioliasisAdolescentPrevalenceHelminthiasisFecesAge groupsparasitic diseasesEpidemiologymedicinePrevalenceFasciola hepaticaAnimalsHumansChildParasite Egg CountFecesAgedAged 80 and overbiologyPublic Health Environmental and Occupational HealthAge FactorsInfant NewbornInfantGeneral MedicineFasciola hepaticaMiddle Agedmedicine.diseasebiology.organism_classificationInfectious DiseasesHuman fascioliasisChild PreschoolParasitologyFemaleTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Analysis of cytokine and specific antibody profiles in hydatid patients with primary infection and relapse of disease

1998

We studied in vitro cytokine production by peripheral blood mononuclear cells (PBMC) from patients with primary and recurrent hydatid disease when cells were incubated with mitogen (PHA) and antigen from hydatid cyst fluid (HCFAg); levels of specific IgE, IgG4 and eosinophil counts were also measured in sera. When specifically stimulated, PBMC from patients produced higher levels of IL-2 (P < 0.02), IFN-γ (P < 0.0028) and IL-5 (P < 0.01) than those from uninfected donors, whereas IL-10 levels were comparable. Notably, IL-5 was also produced in higher levels (P < 0.01) by PBMC from patients when incubated with PHA. The IL-5:IFN-γ ratio was significantly greater (P < 0.02) when measured in re…

AdultMalemedicine.medical_treatmentImmunologyAntibodies HelminthBlood DonorsCell CountStimulationDiseaseImmunoglobulin EPeripheral blood mononuclear cellAntigenEchinococcosisRecurrencemedicineAnimalsHumansPhytohemagglutininsCells CulturedAgedbiologybusiness.industryMiddle AgedEosinophilIn vitroEosinophilsmedicine.anatomical_structureCytokineAntigens HelminthImmunologyLeukocytes Mononuclearbiology.proteinCytokinesCattleFemaleParasitologyMitogensbusinessCell DivisionParasite Immunology
researchProduct

Arterial hypertension due to primary adrenal hydatid cyst.

2002

Adultmedicine.medical_specialtybusiness.industryHelminthiasisAdrenal Gland DiseasesAnticestodal AgentsHydatid cystAdrenalectomymedicine.diseaseAlbendazoleSurgeryEchinococcosisHypertensionmedicineHumansSurgeryFemaleComplicationbusinessTomography X-Ray ComputedSurgery
researchProduct

Physical Activity Scaled to Preferred Walking Speed as a Predictor of Walking Difficulty in Older Adults: A 2-Year Follow-up

2021

Abstract Background The usual accelerometry-based measures of physical activity (PA) are dependent on physical performance. We investigated the associations between PA relative to walking performance and the prevalence and incidence of early and advanced walking difficulties compared to generally used measures of PA. Methods Perceived walking difficulty was evaluated in 994 community-dwelling participants at baseline (age 75, 80, or 85 years) and 2 years later over 2 km (early difficulty) and 500 m (advanced difficulty). We used a thigh-mounted accelerometer to assess moderate-to-vigorous PA, daily mean acceleration, and relative PA as movement beyond the intensity of preferred walking spee…

Agingmedicine.medical_specialtyPhysical activityWalkingmobility limitation03 medical and health sciencesexercise intensity0302 clinical medicinePhysical medicine and rehabilitationcut-pointKilometerAccelerometryHumansMedicine030212 general & internal medicineMobility LimitationExerciseaskelmittaritAgedbusiness.industryIncidence (epidemiology)ennusteetliikuntarajoitteetphysical performancekävelyWalking SpeedPreferred walking speedaccelerometerDifficulty walkingMobility LimitationdisablementExercise intensityObservational studyGeriatrics and Gerontologybusinesshuman activitiesfyysinen aktiivisuusikääntyneet030217 neurology & neurosurgeryFollow-Up StudiesThe Journals of Gerontology: Series A
researchProduct

Telmisartan as metabolic modulator: a new perspective in sports doping?

2011

The World Antidoping Agency (WADA) has introduced some changes in the 2012 prohibited list. Among the leading innovations to the rules are that both 5-aminoimidazole-4-carboxamide-1-[beta]-D-ribofuranoside (peroxisome proliferator�activated receptor-[delta] [PPAR-[delta]]-5' adenosine monophosphate-activated protein kinase [AMPK] agonist) and GW1516 (PPAR-[delta]-agonist) are no longer categorized as gene doping substances in the new 2012 prohibited list but as metabolic modulators in the class �Hormone and metabolic modulators.� This may also be valid for the angotensin II receptor blocker telmisartan. It has recently been shown that telmisartan might induce similar biochemical, biological…

Agonistmedicine.medical_specialtymedicine.drug_classPeroxisome proliferator-activated receptorPhysical Therapy Sports Therapy and RehabilitationdopingBenzoatesMiceGene dopingInternal medicinemedicineAnimalsHumansOrthopedics and Sports MedicineTelmisartanMuscle SkeletalDoping in Sportschemistry.chemical_classificationFiber typeTelmisartan; doping; sport.business.industryAMPKGeneral MedicineRatssport.EndocrinologyMitochondrial biogenesischemistryBenzimidazolesTelmisartanbusinessAngiotensin II Type 1 Receptor Blockersmedicine.drug
researchProduct